Right-To-Try Legislation Must Change Language To Narrow Spectrum Of Patients, Gottlieb Says
US FDA commissioner tells House hearing that the Senate's legislation in its current form could undermine the intent of addressing terminally ill patients.
US FDA commissioner tells House hearing that the Senate's legislation in its current form could undermine the intent of addressing terminally ill patients.